tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

iKena Oncology reports Q3 EPS (21c), consensus (27c)

As of September 30, 2024, the Company had cash, cash equivalents, and marketable securities of $138.0 million.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1